Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: The Effect of Reversal of Remimazolam Sedation With Flumazenil on Cognitive Function in Patients Undergoing Hip Arthroplasty Under Spinal Anesthesia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether reversal of remimazolam sedation with flumazenil influences cognitive function after hip arthroplasty performed under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flumazenil (flumazenil)
  • Remimazolam (remimazolam)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Postoperative Delirium, Sedation | Phase 4 | Status: NOT_YET_RECRUITING